市場調査レポート
商品コード
1123173
子宮内膜症の世界市場予測(2022年~2028年)Global Endometriosis Market Research and Forecast 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
子宮内膜症の世界市場予測(2022年~2028年) |
出版日: 2022年07月24日
発行: Orion Market Research
ページ情報: 英文 100 Pages
納期: 2~3営業日
|
世界の子宮内膜症の市場規模は、予測期間中(2021年~2027年)に3.0%という大きなCAGRで成長すると予測されています。
市場成長を増大させる要因としては、女性の再生産年齢人口の増加、先進国・新興国での疾患に対する認識の高まり、子宮内膜症疾患の研究開発への政府当局の高額な投資などが挙げられます。また、この分野の研究が活発化していることも、市場成長の重要な役割を担っています。しかし、未開発経済圏では熟練労働者がいないこと、高度な治療薬の高コスト、新薬開発のための高額な投資、非侵襲的診断検査が利用できないこと、病気の診断に時間がかかることなどが、市場成長を妨げる抑制要因となっています。
当レポートでは、世界の子宮内膜症市場について調査分析し、市場概要、セグメント・地域別の市場分析、競合情勢、企業プロファイルなど、体系的な情報を提供しています。
Global Endometriosis Market Size, Share & Trends Analysis Report By Drug Type (Gonadotropins Releasing Hormone Agonists, Non-Steroidal Anti-Inflammatory Drug, Progestin, and Oral Contraceptive Pills), By Diagnosis (Ultrasound, Pelvic Exam, Laparoscopy, Magnetic Resonance Imaging (MRI), Hysteroscopy, and Sonohysterography), By Treatment (Hormonal Therapy and Pain Management), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, Mail Order Pharmacies, and E-Commerce) Forecast, 2021-2027
The endometriosis market is growing at a considerable CAGR of 3.0% during the forecast period (2021-2027). The factors that augment the growth of the market include a rise in the female reproductive population, a growing awareness of the disease in the developed and emerging economies, and high investment made by government authorities in the R&D of endometriosis disorders. Moreover, increasing researches in this field also play a vital role in the growth of the market. For instance, World Health Organization aims to support policies and services for endometriosis and collaborates with several civil society and endometriosis patient support groups. However, unavailability of a skilled workforce in the undeveloped economies, high cost of advanced therapeutic drugs, high investment for the development of novel drugs, lack of non-invasive diagnostic tests available and the time required for diagnosing the disease are some of the constraints that are estimated to challenge the growth of the market.
Further, high-cost hormone-based therapies dominate the market, and they play an important role in the patient's endometriosis treatment. As a result, players such as Bayer AG and AbbVie, Inc. offer patient assistance programs to assist patients to decrease their out-of-pocket expenses. Patient access to patient assistance programs for costly prescriptions is likely to increase patient adherence to these treatments, driving the market over the forecast period. Moreover, a lack of awareness among people is also estimated to hinder market growth. For instance, according to the analysis of Endometriosis UK, around 62% of women between the ages of 16-54 years delay their treatment as they think the symptoms are not serious or don't treat due to embarrassment. Conversely, technological advancement in the field by research institutes for the treatment of endometriosis disease and supportive government regulations are some of the opportunities that are estimated for the market players.
Impact of COVID-19 on the Global Endometriosis Market
The global endometriosis market is hardly hit by the COVID-19 pandemic since December 2019. The outbreak of COVID-19 in the major economies has disrupted the diagnosis of endometrioses disease across the globe which resulted in the decrease of market share. This was mainly due to the lockdowns imposed by the governments and only the emergency diagnosis was allowed as the priority was given to the patients suffering from COVID-19. There was a postponement of planned surgical or fertility treatments and an eventual increase in the waitlist for services being observed.
Segmental Outlook
The global endometriosis market is segmented based on drug type, diagnosis, treatment, and distribution channel. Based on the drug type segment, the market is segmented into gonadotropins releasing hormone agonists, non-steroidal anti-inflammatory drugs, progestin, and oral contraceptive pills. Based on the diagnosis segment, the market is segmented into ultrasound, pelvic exam, laparoscopy, magnetic resonance imaging (MRI), hysteroscopy, and sonohysterography. Based on the treatment segment, the market is segmented into hormonal therapy and pain management. Further, based on the distribution channel segment, the market is bifurcated into hospital pharmacies, drug stores, retail pharmacies, mail-order pharmacies, and e-commerce.
Global Endometriosis Market Share by Diagnosis, 2020 (%)
Global Endometriosis Market Share by Diagnosis
Pelvic Exam Segment to Hold a Lucrative Share in the Global Endometriosis market
Amongst the diagnosis type segment of the global endometriosis market, the pelvic exam segment was estimated to have one of the largest shares in the diagnosis segment for the endometriosis market. The pelvic exam is carried out manually by the doctor for checking the size of the ovaries and uterus and noting any tender areas or unusual growths. Besides, the laparoscopy segment also had a significant contribution to the growth of the market. The ability of this surgery to effectively diagnose endometriosis and even remove it in mild-moderate cases with only a minor incision has led to increased demand and revenue. Increasing adoption of minimally invasive surgeries and growth in healthcare infrastructure with technological advancement are some of the factors that promote the growth of the laparoscopy market. This is performed by placing a video camera through the trocar and is used to see the inside and abdomen of a patient.
Regional Outlooks
The global endometriosis market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America (the US and Canada), Europe (Germany, Spain, Italy, France, the UK, and the Rest of Europe), Asia-Pacific (India, China, Japan South Korea, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East and Africa, and Latin America). North America region is estimated to have one of the largest shares in this market. The high prevalence of the female population suffering from endometriosis disease, high awareness among people regarding health issues, high healthcare infrastructure, and availability of prominent market players are some of the factors that drive the growth of the market in this region. Europe is also estimated to have a significant contribution owing to the presence of refined healthcare infrastructure.
Endometriosis Market, by Region 2021-2027
Endometriosis Market, by Region
Asia-Pacific is projected to highest Contributor to the growth of the Global Endometriosis market
Asia-Pacific is estimated to be one of the fastest-growing regions owing to the rise in the number of generic manufacturers and the increase in the prevalence of endometriosis disease with the rise in population in emerging economies like China and India. Besides, the region's rapid growth is due to continued advancements in healthcare technologies and increased awareness of women's health.
Market Player Outlook
Key players of the endometriosis market include Abbott Laboratories, AbbVie Inc., Bayer AG, AstraZeneca plc, Pfizer Inc., Takeda Pharmaceutical Company Ltd., Neurocrine Biosciences, Inc., and Sanofi S.A, among others. To survive in the market these players adopt different marketing strategies such as a merger, acquisitions, product launch, and geographical expansion so on. For instance, in May 2020, AbbVie completed the acquisition of Allergan plc $193.23 per Allergan share to increase the company's therapeutic categories.
The Report Covers
Market value data analysis of 2020 and forecast to 2027.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global endometriosis market based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where in the market